FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067997 [Registered on: 28/05/2024] Trial Registered Prospectively
Last Modified On: 29/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Investigating how a special super inductive magnetic device can help ease muscle pain caused by Myofasical Pain Ssyndrome (MPS). 
Scientific Title of Study   Isolation effect of Functional Magnetic Stimulator (FMS) on Myofascial Pain Syndrome (MPS). 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Shilpa Jain 
Designation  Associate Professor 
Affiliation  Delhi Pharmaceutical Science And Research University 
Address  Room no. 604, 6th floor, School of Physiotherapy, Delhi Pharmaceutical Sciences and Research University Mehrauli - Badarpur Rd, opp. Sainik Farm, Sector 3, Tughlakabad, New Delhi, 110017

South
DELHI
110017
India 
Phone  7060443388  
Fax    
Email  shilpa.jain36@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Shreya Mishra 
Designation  Post Gradute Student 
Affiliation  Delhi Pharmaceutical Science And Research University 
Address  Room No.C-5,PG Building, DPSRU Girls Hostel,Delhi Pharmaceutical Sciences and Research University Mehrauli - Badarpur Rd, opp. Sainik Farm, Sector 3, Tughlakabad, New Delhi, 110017

South
DELHI
110017
India 
Phone  7060443388  
Fax    
Email  shreyamishra988@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Shilpa Jain 
Designation  Associate Professor 
Affiliation  Delhi Pharmaceutical Science And Research University 
Address  Room no.604, 6th Floor, School of Physiotherapy, Delhi Pharmaceutical Sciences and Research University Mehrauli - Badarpur Rd, opp. Sainik Farm, Sector 3, Tughlakabad, New Delhi, 110017

South
DELHI
110017
India 
Phone  7060443388  
Fax    
Email  shilpa.jain36@gmail.com  
 
Source of Monetary or Material Support  
School Of Physiotherapy, Delhi Pharmaceutical Sciences and Research University Mehrauli - Badarpur Rd, opp. Sainik Farm, Sector 3, Tughlakabad, New Delhi, 110017  
 
Primary Sponsor  
Name  School Of Physiotherapy Delhi Pharmaceutical Science And Research University 
Address  6th floor School of Physiotherapy, Delhi Pharmaceutical Sciences and Research University Mehrauli - Badarpur Rd, opp. Sainik Farm, Sector 3, Tughlakabad, New Delhi, 110017 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shilpa Jain  School Of Physiotherapy, OPD  OPD, Ground floor, School of Physiotherapy, Delhi Pharmaceutical Sciences and Research University Mehrauli - Badarpur Rd, opp. Sainik Farm, Sector 3, Tughlakabad, New Delhi 110017
South
DELHI 
7060443388

shilpa.jain36@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Students Research Development Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M791||Myalgia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional Treatmment  For subjects receiving Conventional Treatment: Hot Fomentation:- 10 mins Stretching of Trapezius muscle Ultrasound Therapy: 1.2 W/cm2 Frequency: 1 MHz Mode: Continuous. Duration:-For 3 days/week for 3 weeks. Subject will be assesed on baseline assessment and final assesment.  
Intervention  Functional Magnetic Stimulator  For subjects receiving Functional Magnetic Stimulation: The super inductive stimulator (the BTL-6000 Super Inductive System, by BTL Industries Ltd.) will be used to perform the therapy. Duration:- For 3 days/week for 3weeks. Subject will be assesed on baseline assessment and final assesment. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  In order to participate in the study, individuals must experience both an active trigger point in the upper trapezius muscle and mechanical pain in the cervical region that has lasted for less than three months. Additionally, the pain intensity in the neck and cervical regions should be moderate, ranging from 3 to 8 on a Visual Analogue Scale (VAS) taken within the past 30 days, and the Neck Disability Index score should fall between 15 and 34 (inclusive). 
 
ExclusionCriteria 
Details  Individuals with the following conditions will be excluded from the study: radicular syndrome (pain radiating down the arm), whiplash injury, or any diagnosed cervical pathology like a herniated disc. Additionally, those currently receiving treatment for neck or shoulder pain, using pain medication (analgesics, anti-inflammatory drugs, muscle relaxants), anticoagulant medications, or having a history of psychological/psychiatric conditions, active cancer, or who have undergone invasive spinal procedures within the last 4-6 months will not be eligible to participate. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduce pain and improvement in range of motion.  Baseline
After 3 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in functional mobility.  Baseline
After 3 weeks 
 
Target Sample Size   Total Sample Size="54"
Sample Size from India="54" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   03/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  03/06/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study will compare two group for pain relief. Both groups will receive treatment for 3 days per week for 3 weeks.
1. For subjects receiving Functional Magnetic Stimulation (FMS) will be delivered using the super inductive stimulator (The BTL-6000 Super Inductive System, by BTL Industries Ltd.) for 10 minutes with an acute analgesic protocol.
2. For subjects receiving conventional treatment will include hot fomentation for 10 minutes, stretching of the trapezius muscle, and continuous ultrasound therapy at 1 MHz and 1.2 W/cm2.
 
Close